Skip to Main Content
Services Talent Knowledge
Site Search


December 3, 2009

Symposium to Discuss Key Intellectual Property Issues in India

Leading intellectual property attorney Mark Peroff, Co-Chair of law firm Hiscock & Barclay LLP's Intellectual Property & Technology Practice Area, will be attending the Fédération Internationale des Conseils en Propriété Industrielle's (FICPI) India Symposium in New Delhi, where a number of key intellectual property issues for Indian companies will be discussed. FICPI is world-wide organization of intellectual property attorneys and the symposium will take place from December 9-11.

Recently, Hiscock & Barclay launched trademark services for companies from India, an effort which is being led by Mr. Peroff, who is one of the leading trademark attorneys in the United States, having filed more than 6,700 trademarks over the course of his career.

With its leading pharmaceutical companies and a rapidly growing high-tech sector, India has emerged as an important country in the world of IP. The FICPI India Symposium will address a wide range of topics affecting IP professionals, including a session on "Generic Pharma v. Research Based Pharma" and "Protection of IT and Software."


Click here to sign up for alerts, blog posts, and firm news.


Sign up to receive our latest news via email

Practice Areas

Featured Industries

New & Emerging Industry Practice Areas


View our Privacy Policy

Featured Media


COVID-19: NYS Governor Cuomo Announces Additional Aid for Small Businesses


COVID-19: Additional Loan Forgiveness Guidance


COVID-19: OPWDD Updates Billing Guidance for Certain Providers


COVID-19: Eligible Massachusetts Businesses Begin Reopening Under Commonwealth's Four-Phase Plan


NYS Statutes of Limitation Further Tolled During COVID-19


COVID-19: Eligible Connecticut Businesses to Open May 20

This site uses cookies to give you the best experience possible on our site and in some cases direct advertisements to you based upon your use of our site.

By clicking [I agree], you are agreeing to our use of cookies. For information on what cookies we use and how to manage our use of cookies, please visit our Privacy Statement.

I AgreeOpt-Out